325-OR: Enhancing Physical Activity Engagement among Individuals with Type 1 Diabetes—Exploring Perceived Barriers in the Era of New Technologies - Université de Lille
Article Dans Une Revue Diabetes Année : 2024

325-OR: Enhancing Physical Activity Engagement among Individuals with Type 1 Diabetes—Exploring Perceived Barriers in the Era of New Technologies

Résumé

Background: Physical activity benefits people with type 1 diabetes (PwT1D); however, PwT1D appear less active than their nondiabetic peers. This study seeks to investigate the potential of diabetes technologies in mitigating perceived barriers to physical activity in type 1 diabetes (T1D). Methods: A cross-sectional study with participants from the BETTER registry (age> 14 years) who completed BAPAD-1 (Barriers to Physical Activity in T1D) questionnaire. A significant barrier is defined by score > 5 to BAPAD-1 items. Four groups were defined according to the participants' treatment and blood glucose monitoring mode: Multiple daily injections (MDI) without continuous glucose monitoring (CGM), MDI with CGM, pump with CGM, and those using an automated insulin delivery system (AID). Results: Among 1019 eligible participants, the main perceived barrier is the fear of hypoglycemia. The mean BAPAD-1 score is similar for all groups. A higher proportion of individuals using AID systems reported significant barriers for items fear of hypoglycemia and loss of control over their diabetes compared to the No-CGM-MDI (+20% both), CGM-MDI (+7% and +10%), and CGM+Pump (+9% and +7%). Conclusion: Barriers to physical activity for PwT1D are not reduced by diabetes technologies. Some barriers are even perceived as more important for people using CGM, pump, and AID systems.
Fichier non déposé

Dates et versions

hal-04792369 , version 1 (20-11-2024)

Identifiants

Citer

Capucine Guédet, Semah Tagougui, Virginie Messier, Valerie Boudreau, Anne-Sophie Brazeau, et al.. 325-OR: Enhancing Physical Activity Engagement among Individuals with Type 1 Diabetes—Exploring Perceived Barriers in the Era of New Technologies. Diabetes, 2024, Diabetes, 71 (Supp.1), ⟨10.2337/db24-325-or⟩. ⟨hal-04792369⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More